dipyridamole has been researched along with MODS in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cullis, PS | 1 |
| Watson, D | 1 |
| Cameron, A | 1 |
| McKee, RF | 1 |
| Babaoglu, MO | 1 |
| Karadag, O | 1 |
| Saikawa, Y | 1 |
| Altundag, K | 1 |
| Elkiran, T | 1 |
| Yasar, U | 1 |
| Bozkurt, A | 1 |
1 review available for dipyridamole and MODS
| Article | Year |
|---|---|
Dipyridamole and paracetamol overdose resulting in multi-organ failure.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Depression; Dipyridamole; Drug Overdose; Female; Hospitaliz | 2013 |
1 other study available for dipyridamole and MODS
| Article | Year |
|---|---|
Hepatotoxicity due to a possible interaction between cytosine arabinoside and dipyridamole: a case report.
Topics: Antimetabolites, Antineoplastic; Blood Cell Count; Chemical and Drug Induced Liver Injury; Cytarabin | 2004 |